Literature DB >> 28085163

PSMA-targeted contrast agents for intraoperative imaging of prostate cancer.

Kai Bao1, Jeong Heon Lee, Homan Kang, G Kate Park, Georges El Fakhri, Hak Soo Choi.   

Abstract

Prostate-specific membrane antigen (PSMA) can serve as a molecular cell surface target for the detection and treatment of prostate cancer. Near-infrared (NIR) fluorescence imaging enables highly sensitive, rapid, and non-radioactive imaging of PSMA, though specific targeting still remains a challenge because no optimized contrast agents exist.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28085163      PMCID： PMC5728657          DOI： 10.1039/c6cc09781b

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  31 in total

Review 1.  Targeting nanoparticles to cancer.

Authors:  M Wang; M Thanou
Journal:  Pharmacol Res       Date:  2010-04-07       Impact factor: 7.658

2.  Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate.

Authors:  Takahito Nakajima; Makoto Mitsunaga; Neil H Bander; Warren D Heston; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2011-07-27       Impact factor: 4.774

3.  High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen.

Authors:  Valerie Humblet; Rena Lapidus; Larry R Williams; Takashi Tsukamoto; Camilo Rojas; Pavel Majer; Bunda Hin; Shunsuke Ohnishi; Alec M De Grand; Atif Zaheer; Jürgen T Renze; Akira Nakayama; Barbara S Slusher; John V Frangioni
Journal:  Mol Imaging       Date:  2005 Oct-Dec       Impact factor: 4.488

4.  PSMA-targeted stably linked "dendrimer-glutamate urea-methotrexate" as a prostate cancer therapeutic.

Authors:  Baohua Huang; James Otis; Melvin Joice; Alina Kotlyar; Thommey P Thomas
Journal:  Biomacromolecules       Date:  2014-02-10       Impact factor: 6.988

5.  cGMP-Compatible preparative scale synthesis of near-infrared fluorophores.

Authors:  Hoon Hyun; Mark W Bordo; Khaled Nasr; Dina Feith; Jeong Heon Lee; Soon Hee Kim; Yoshitomo Ashitate; Lorissa A Moffitt; Mireille Rosenberg; Maged Henary; Hak Soo Choi; John V Frangioni
Journal:  Contrast Media Mol Imaging       Date:  2012 Nov-Dec       Impact factor: 3.161

6.  Tissue-Specific Near-Infrared Fluorescence Imaging.

Authors:  Eric A Owens; Maged Henary; Georges El Fakhri; Hak Soo Choi
Journal:  Acc Chem Res       Date:  2016-08-26       Impact factor: 22.384

Review 7.  Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen.

Authors:  G P Murphy; A A Elgamal; S L Su; D G Bostwick; E H Holmes
Journal:  Cancer       Date:  1998-12-01       Impact factor: 6.860

8.  Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).

Authors:  Sangeeta R Banerjee; Catherine A Foss; Mark Castanares; Ronnie C Mease; Youngjoo Byun; James J Fox; John Hilton; Shawn E Lupold; Alan P Kozikowski; Martin G Pomper
Journal:  J Med Chem       Date:  2008-07-19       Impact factor: 7.446

9.  Production of multimeric prostate-specific membrane antigen small-molecule radiotracers using a solid-phase 99mTc preloading strategy.

Authors:  Preeti Misra; Valerie Humblet; Nadine Pannier; Wolfgang Maison; John V Frangioni
Journal:  J Nucl Med       Date:  2007-07-13       Impact factor: 10.057

10.  Charge and hydrophobicity effects of NIR fluorophores on bone-specific imaging.

Authors:  Kai Bao; Khaled A Nasr; Hoon Hyun; Jeong Heon Lee; Julien Gravier; Summer L Gibbs; Hak Soo Choi
Journal:  Theranostics       Date:  2015-03-01       Impact factor: 11.556
View more
  8 in total

1.  Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors.

Authors:  James Kelly; Alejandro Amor-Coarasa; Shashikanth Ponnala; Anastasia Nikolopoulou; Clarence Williams; David Schlyer; Yize Zhao; Dohyun Kim; John W Babich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-06       Impact factor: 9.236

2.  A Fluorescent, [18F]-Positron-Emitting Agent for Imaging Prostate-Specific Membrane Antigen Allows Genetic Reporting in Adoptively Transferred, Genetically Modified Cells.

Authors:  Hua Guo; Harikrishna Kommidi; Yogindra Vedvyas; Jaclyn E McCloskey; Weiqi Zhang; Nandi Chen; Fuad Nurili; Amy P Wu; Haluk B Sayman; Oguz Akin; Erik A Rodriguez; Omer Aras; Moonsoo M Jin; Richard Ting
Journal:  ACS Chem Biol       Date:  2019-06-17       Impact factor: 5.100

Review 3.  Not so innocent: Impact of fluorophore chemistry on the in vivo properties of bioconjugates.

Authors:  Syed Muhammad Usama; Ek Raj Thapaliya; Michael P Luciano; Martin J Schnermann
Journal:  Curr Opin Chem Biol       Date:  2021-03-05       Impact factor: 8.972

4.  Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer.

Authors:  Margret Schottelius; Alexander Wurzer; Katharina Wissmiller; Roswitha Beck; Maximilian Koch; Dimitrios Gorpas; Johannes Notni; Tessa Buckle; Matthias N van Oosterom; Katja Steiger; Vasilis Ntziachristos; Markus Schwaiger; Fijs W B van Leeuwen; Hans-Jürgen Wester
Journal:  J Nucl Med       Date:  2018-09-20       Impact factor: 10.057

5.  Image-Guided Surgery: Are We Getting the Most Out of Small-Molecule Prostate-Specific-Membrane-Antigen-Targeted Tracers?

Authors:  Albertus Wijnand Hensbergen; Danny M van Willigen; Florian van Beurden; Pim J van Leeuwen; Tessa Buckle; Margret Schottelius; Tobias Maurer; Hans-Jürgen Wester; Fijs W B van Leeuwen
Journal:  Bioconjug Chem       Date:  2020-01-06       Impact factor: 4.774

6.  In Vitro and In Vivo Cell Uptake of a Cell-Penetrating Peptide Conjugated with Fluorescent Dyes Having Different Chemical Properties.

Authors:  Hideo Takakura; Honoka Sato; Kohei Nakajima; Motofumi Suzuki; Mikako Ogawa
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

7.  Tuned near infrared fluorescent hyaluronic acid conjugates for delivery to pancreatic cancer for intraoperative imaging.

Authors:  Bowen Qi; Ayrianne J Crawford; Nicholas E Wojtynek; Geoffrey A Talmon; Michael A Hollingsworth; Quan P Ly; Aaron M Mohs
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556

Review 8.  PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery.

Authors:  Yvonne H W Derks; Dennis W P M Löwik; J P Michiel Sedelaar; Martin Gotthardt; Otto C Boerman; Mark Rijpkema; Susanne Lütje; Sandra Heskamp
Journal:  Theranostics       Date:  2019-09-20       Impact factor: 11.556
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.